The monitoring program is a formal step that WADA uses to evaluate whether substances should move to the Prohibited List
occasional reports of mild headache, transient jitteriness, or injection-site reactions
Back to Journals Diabetes, Metabolic Syndrome and Obesity Volume 14 Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products Authors Jakab J , Miki B, Miki S, Jurani B, osi V, Schwarz D, Vev A Received 10 September 2020 Accepted for publication 9 December 2020 Published 8 January 2021 Volume 2021:14 Pages 6783 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Prof
Other indications include malabsorption disorders (such as Crohn's disease or coeliac disease), following gastric surgery, strict vegan diets without supplementation, and certain medications that interfere with B12 absorption
Studies on the use of BPC-157 following orthopedic surgeries
Dairy: Milk, cheese, and yoghurt